Guidelines for proton pump inhibitor prescriptions in paediatric intensive care unit

详细信息    查看全文

• 作者：P. Joret-Descout ; S. Dauger ; M. Bellaiche…
• 关键词：Drug prescriptions ; France ; Guidelines ; Intensive care unit ; Off ; label prescribing ; Pediatrics ; Proton pump inhibitors
• 刊名：International Journal of Clinical Pharmacy
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：39
• 期：1
• 页码：181-186
• 全文大小：
• 刊物类别：Medicine
• 刊物主题：Internal Medicine; Pharmacy;
• 出版者：Springer International Publishing
• ISSN：2210-7711
• 卷排序：39

文摘

Background Stress ulcer prophylaxis (SUP) is recommended in some situations to prevent upper gastrointestinal bleeding and is a component of standard care for patients admitted to the intensive care unit (ICU). Proton pump inhibitors (PPIs), already among the most widely prescribed drug classes, are being increasingly used. Objective To describe PPI prescribing patterns and their changes after the dissemination of guidelines. Setting Paediatric ICU (PICU), Robert-Debré Teaching Hospital, Paris, France, which admits about 800 patients annually, from full-term neonates to 18-year-olds. Method Prospective observational study with two 6-week observation periods (July–August and September–October, 2013), before and after dissemination in the PICU of PPI prescribing guidelines. Main outcome measure Changes in PPI prescribing patterns (prevalence, dosage, and indication) after the guidelines. Results The number of patients admitted to the PICU was 77 (mean age 4.6 years [range 1 day–18 years]) before and 70 (mean age 3.8 years [range 1 day–17 years]) after the guidelines. During both periods, SUP was the most common reason for PPI prescribing. The proportion of patients prescribed PPIs dropped significantly, from 51% before the guidelines to 30% after the guidelines (p < 0.001). Mean daily dosage also decreased significantly, from 1.5 mg/kg/(range 0.5–4.4) to 1.1 mg/kg (range 0.7–1.8) (p < 0.002). None of the patients experienced upper gastrointestinal bleeding during either period. Conclusion Off-label PPI prescribing for SUP was common in our PICU. The introduction of guidelines was associated with a significant decrease in PPI use and dosage. This study confirms that guidelines can change PPI prescribings patterns in paediatric practice.